Addus HomeCare (NASDAQ:ADUS) Receives New Coverage from Analysts at KeyCorp

Investment analysts at KeyCorp began coverage on shares of Addus HomeCare (NASDAQ:ADUS) in a note issued to investors on Friday, Briefing.com reports. The firm set an “overweight” rating and a $150.00 price target on the stock. KeyCorp’s target price indicates a potential upside of 17.70% from the company’s current price.

A number of other brokerages have also issued reports on ADUS. StockNews.com lowered Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research report on Sunday, July 7th. TD Cowen upped their price objective on shares of Addus HomeCare from $128.00 to $137.00 and gave the company a “buy” rating in a research note on Thursday, August 8th. Oppenheimer raised their target price on shares of Addus HomeCare from $140.00 to $145.00 and gave the stock an “outperform” rating in a report on Monday, September 23rd. Stephens restated an “overweight” rating and set a $138.00 price target on shares of Addus HomeCare in a report on Tuesday, August 6th. Finally, Royal Bank of Canada reiterated an “outperform” rating and set a $141.00 price objective on shares of Addus HomeCare in a research report on Tuesday, September 3rd. One investment analyst has rated the stock with a sell rating and nine have given a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $131.00.

Addus HomeCare Price Performance

Shares of NASDAQ:ADUS opened at $127.44 on Friday. The stock has a market cap of $2.31 billion, a price-to-earnings ratio of 30.20, a PEG ratio of 2.33 and a beta of 1.04. Addus HomeCare has a 12 month low of $78.35 and a 12 month high of $136.12. The stock’s 50 day moving average price is $129.34 and its 200 day moving average price is $116.95.

Addus HomeCare (NASDAQ:ADUS) last announced its earnings results on Monday, August 5th. The company reported $1.35 earnings per share for the quarter, beating the consensus estimate of $1.21 by $0.14. Addus HomeCare had a return on equity of 9.81% and a net margin of 6.18%. The business had revenue of $286.90 million during the quarter, compared to analysts’ expectations of $284.90 million. During the same quarter last year, the business posted $0.94 earnings per share. The company’s quarterly revenue was up 10.4% on a year-over-year basis. On average, sell-side analysts expect that Addus HomeCare will post 4.58 EPS for the current year.

Insider Buying and Selling at Addus HomeCare

In related news, EVP Michael D. Wattenbarger sold 21,917 shares of the stock in a transaction on Monday, August 26th. The stock was sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the completion of the sale, the executive vice president now directly owns 7,215 shares in the company, valued at approximately $961,687.35. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, EVP Michael D. Wattenbarger sold 21,917 shares of the business’s stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $133.29, for a total value of $2,921,316.93. Following the completion of the sale, the executive vice president now owns 7,215 shares of the company’s stock, valued at approximately $961,687.35. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Esteban Lopez sold 500 shares of Addus HomeCare stock in a transaction that occurred on Tuesday, September 10th. The shares were sold at an average price of $127.50, for a total transaction of $63,750.00. Following the completion of the sale, the director now owns 3,366 shares of the company’s stock, valued at $429,165. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 22,917 shares of company stock valued at $3,050,082 in the last quarter. Company insiders own 4.60% of the company’s stock.

Institutional Trading of Addus HomeCare

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Ellsworth Advisors LLC acquired a new position in Addus HomeCare in the 2nd quarter valued at $598,000. Quadrature Capital Ltd acquired a new position in shares of Addus HomeCare during the 1st quarter worth about $1,557,000. Lord Abbett & CO. LLC bought a new stake in Addus HomeCare during the 1st quarter valued at approximately $8,274,000. Vanguard Group Inc. grew its holdings in Addus HomeCare by 3.2% in the 4th quarter. Vanguard Group Inc. now owns 1,257,440 shares of the company’s stock valued at $116,753,000 after buying an additional 38,876 shares during the last quarter. Finally, SG Americas Securities LLC bought a new position in Addus HomeCare in the 2nd quarter worth approximately $842,000. Institutional investors and hedge funds own 95.35% of the company’s stock.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.